GI Dynamics Inc  

(Public, ASX:GID)   Watch this stock  
Find more results for GID
0.150
0.000 (0.00%)
Jun 30 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.15 - 0.15
52 week 0.10 - 0.61
Open 0.15
Vol / Avg. 112,098.00/180,814.00
Mkt cap 72.95M
P/E     -
Div/yield     -
EPS -0.14
Shares 9.48M
Beta     -
Inst. own     -
Jun 9, 2015
GI Dynamics Inc Annual Shareholders Meeting - Webcast
May 22, 2015
GI Dynamics Inc Annual Shareholders Meeting (Estimated)
May 6, 2015
Q1 2015 GI Dynamics Inc Earnings Call - Webcast
May 5, 2015
Q1 2015 GI Dynamics Inc Earnings Release
  

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -1680.03% -1704.56%
Operating margin -1602.27% -1704.03%
EBITD margin - -1680.83%
Return on average assets -77.27% -74.84%
Return on average equity -91.53% -85.65%
Employees 38 -
CDP Score - -

Address

1 Maguire Rd
LEXINGTON, MA 02421-3114
United States - Map
+1-781-3573310 (Phone)
+1-781-3573301 (Fax)

Website links

Description

GI Dynamics, Inc. designs, develops, and markets medical devices for non-surgical approaches to treating type 2 diabetes and obesity. The Company has commercially launched its lead product, the EndoBarrier. EndoBarrier Therapy is a treatment for people whose diabetes medications are no longer effective, who are at risk for serious health complications from their diabetes and excess weight and who want to avoid surgery or the progression to injectable therapy. The Company’s product is sold to customers located in Europe, the Middle East, Australia and South America. The Company is focused on the commercial rollout of the EndoBarrier in selected countries in Europe and South America, as well as in Australia and Israel. In the United States, it has received approval from the United States Food and Drug Administration (FDA), to commence its clinical trial, which began in 2013.

Officers and directors

Andy Levine Chief Technology Officer
Age: 54
Karl-Heinz Blohm Ph.D. Vice President - International Sales
Sherrie Coval-Goldsmith Vice President - Clinical and Regulatory Affairs
Anthony Tremaglio Senior Director of Marketing
Gerd Gottschalk Reimbursement Director
Anthony Switzer Commercial Development - Australia
Michael Donald Dale President, Chief Executive Officer, Director
Age: 54
Jack Edward Meyer Independent Non-Executive Chairman of the Board
Age: 65
Michael A. Carusi Non-Independent Non-Executive Director
Daniel Jeffrey Moore Independent Director
Age: 54